A closer look at the technologies used by Galectin Sciences
Galectin Sciences
Business Services · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Georgia, United StatesWebsite
www.galectinsciences.comRevenue
<$5 MillionIndustry
About Galectin Sciences
Is Galectin Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Galectin Sciences is spiking on competitors!
Click to see if Galectin Sciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Galectin Sciences has new funding data
Earning: See what the market has to say on Galectin Sciences recently announced quarterly report
Check if Galectin Sciences has recently received funding, and reach out quickly before it becomes old news!
Galectin Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Galectin Sciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Galectin Sciences launches new products
Recommended Actions
Find VP level buyers at Galectin Sciences
Find 2 more new buyers
Compare Similar Companies to Galectin Sciences
Compare insights from companies similar to Galectin Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Galectin Sciences
Galectin Sciences Tech Stack
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Galectin Sciences
Galectin Sciences, LLC is a collaborative venture focused on researching and developing small organic molecule inhibitors of galectin-3 for oral administration. Jointly owned by Galectin Therapeutics and SBH Sciences, the company aims to leverage their combined expertise to create drug candidates targeting galectin proteins implicated in various di... Read More